Andrew N Nicolaides, Andrie G Panayiotou, Maura Griffin, Theodosis Tyllis, Dawn Bond, Niki Georgiou, Efthyvoulos Kyriacou, Costantinos Avraamides, Luca Saba, Elena Critselis, Christiana Demetriou, Despo Ierodiakonou, Annalisa Quattrocchi, Pascale Salameh, Eleni L Tolma, Christos Varounis, Richard M Martin
{"title":"心血管风险与颈动脉分叉斑块产生< 50%狭窄相关,并通过股骨总斑块的存在进行调节:一项队列研究","authors":"Andrew N Nicolaides, Andrie G Panayiotou, Maura Griffin, Theodosis Tyllis, Dawn Bond, Niki Georgiou, Efthyvoulos Kyriacou, Costantinos Avraamides, Luca Saba, Elena Critselis, Christiana Demetriou, Despo Ierodiakonou, Annalisa Quattrocchi, Pascale Salameh, Eleni L Tolma, Christos Varounis, Richard M Martin","doi":"10.1177/1358863X251358270","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aims were to determine the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) in individuals free from ASCVD (a) in the presence of carotid bifurcation plaques (CBP) < 3-mm thick and ⩾ 3 mm in comparison to a normal vessel wall and (b) the risk modulation in the presence or absence of additional common femoral bifurcations with plaques (CFBP) in a cohort study.MethodsA total of 1000 subjects aged 58.4 ± 10.5 years, free from ASCVD, were followed up for 15.2 ± 4.9 years (mean ± SD). The primary endpoint was a composite of first time fatal or nonfatal 10-year ASCVD events.ResultsThe 10-year risk of ASCVD was 6% in the absence of carotid plaques; 10% in the presence of unilateral and 23% in the presence of bilateral < 3-mm plaques (adjusted hazard ratio [HR] 1.65 [95% CI 1.11-2.47] and 2.03 [95% CI 1.32-3.00], respectively); and 29% for unilateral and 63% for bilateral 3-5 mm plaques (adjusted HR 2.40 [95% CI 1.41-4.09] and 3.78 [95% CI 1.77-8.06], respectively). In those with unilateral or bilateral < 3-mm CBP in the presence of two CFBP, the 10-year risk of ASCVD was 26% and 37% (adjusted HR 3.01 [95% CI 1.38-6.58] and 2.52 [95% CI 1.55-4.10], respectively). The 10-year risk was 2% in those without CBP or CFBP and 26% in those with two CFBP only.ConclusionsThe presence of a < 3-mm CBP may be associated with a significant ASCVD risk, especially if bilateral. This risk is better defined by the additional presence or absence of two CFBPs.</p>","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"1358863X251358270"},"PeriodicalIF":3.3000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cardiovascular risk associated with carotid bifurcation plaques producing < 50% stenosis and its modulation by presence of common femoral plaques: A cohort study.\",\"authors\":\"Andrew N Nicolaides, Andrie G Panayiotou, Maura Griffin, Theodosis Tyllis, Dawn Bond, Niki Georgiou, Efthyvoulos Kyriacou, Costantinos Avraamides, Luca Saba, Elena Critselis, Christiana Demetriou, Despo Ierodiakonou, Annalisa Quattrocchi, Pascale Salameh, Eleni L Tolma, Christos Varounis, Richard M Martin\",\"doi\":\"10.1177/1358863X251358270\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The aims were to determine the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) in individuals free from ASCVD (a) in the presence of carotid bifurcation plaques (CBP) < 3-mm thick and ⩾ 3 mm in comparison to a normal vessel wall and (b) the risk modulation in the presence or absence of additional common femoral bifurcations with plaques (CFBP) in a cohort study.MethodsA total of 1000 subjects aged 58.4 ± 10.5 years, free from ASCVD, were followed up for 15.2 ± 4.9 years (mean ± SD). The primary endpoint was a composite of first time fatal or nonfatal 10-year ASCVD events.ResultsThe 10-year risk of ASCVD was 6% in the absence of carotid plaques; 10% in the presence of unilateral and 23% in the presence of bilateral < 3-mm plaques (adjusted hazard ratio [HR] 1.65 [95% CI 1.11-2.47] and 2.03 [95% CI 1.32-3.00], respectively); and 29% for unilateral and 63% for bilateral 3-5 mm plaques (adjusted HR 2.40 [95% CI 1.41-4.09] and 3.78 [95% CI 1.77-8.06], respectively). In those with unilateral or bilateral < 3-mm CBP in the presence of two CFBP, the 10-year risk of ASCVD was 26% and 37% (adjusted HR 3.01 [95% CI 1.38-6.58] and 2.52 [95% CI 1.55-4.10], respectively). The 10-year risk was 2% in those without CBP or CFBP and 26% in those with two CFBP only.ConclusionsThe presence of a < 3-mm CBP may be associated with a significant ASCVD risk, especially if bilateral. This risk is better defined by the additional presence or absence of two CFBPs.</p>\",\"PeriodicalId\":23604,\"journal\":{\"name\":\"Vascular Medicine\",\"volume\":\" \",\"pages\":\"1358863X251358270\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vascular Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/1358863X251358270\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1358863X251358270","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
背景:目的是确定无ASCVD个体的动脉粥样硬化性心血管疾病(ASCVD)的10年风险(a)与正常血管壁相比,存在颈动脉分叉斑块(CBP) < 3毫米厚且大于或等于3毫米,以及(b)在队列研究中存在或不存在斑块(CFBP)的其他常见股骨分叉的风险调节。方法1000例无ASCVD患者,年龄58.4±10.5岁,随访15.2±4.9年(mean±SD)。主要终点是首次致死性或非致死性10年ASCVD事件的综合。结果在没有颈动脉斑块的情况下,ASCVD的10年风险为6%;单侧斑块为10%,双侧< 3-mm斑块为23%(校正风险比分别为1.65 [95% CI 1.11-2.47]和2.03 [95% CI 1.32-3.00]);单侧为29%,双侧3-5 mm斑块为63%(调整后危险度分别为2.40 [95% CI 1.41-4.09]和3.78 [95% CI 1.77-8.06])。在单侧或双侧CBP < 3-mm且存在两例CFBP的患者中,ASCVD的10年风险分别为26%和37%(调整后危险度分别为3.01 [95% CI 1.38-6.58]和2.52 [95% CI 1.55-4.10])。没有CBP或CFBP的10年风险为2%,只有两个CFBP的10年风险为26%。结论CBP < 3mm可能与ASCVD风险相关,尤其是双侧。这种风险最好由两个cfbp的额外存在或不存在来定义。
Cardiovascular risk associated with carotid bifurcation plaques producing < 50% stenosis and its modulation by presence of common femoral plaques: A cohort study.
Background: The aims were to determine the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) in individuals free from ASCVD (a) in the presence of carotid bifurcation plaques (CBP) < 3-mm thick and ⩾ 3 mm in comparison to a normal vessel wall and (b) the risk modulation in the presence or absence of additional common femoral bifurcations with plaques (CFBP) in a cohort study.MethodsA total of 1000 subjects aged 58.4 ± 10.5 years, free from ASCVD, were followed up for 15.2 ± 4.9 years (mean ± SD). The primary endpoint was a composite of first time fatal or nonfatal 10-year ASCVD events.ResultsThe 10-year risk of ASCVD was 6% in the absence of carotid plaques; 10% in the presence of unilateral and 23% in the presence of bilateral < 3-mm plaques (adjusted hazard ratio [HR] 1.65 [95% CI 1.11-2.47] and 2.03 [95% CI 1.32-3.00], respectively); and 29% for unilateral and 63% for bilateral 3-5 mm plaques (adjusted HR 2.40 [95% CI 1.41-4.09] and 3.78 [95% CI 1.77-8.06], respectively). In those with unilateral or bilateral < 3-mm CBP in the presence of two CFBP, the 10-year risk of ASCVD was 26% and 37% (adjusted HR 3.01 [95% CI 1.38-6.58] and 2.52 [95% CI 1.55-4.10], respectively). The 10-year risk was 2% in those without CBP or CFBP and 26% in those with two CFBP only.ConclusionsThe presence of a < 3-mm CBP may be associated with a significant ASCVD risk, especially if bilateral. This risk is better defined by the additional presence or absence of two CFBPs.
期刊介绍:
The premier, ISI-ranked journal of vascular medicine. Integrates the latest research in vascular biology with advancements for the practice of vascular medicine and vascular surgery. It features original research and reviews on vascular biology, epidemiology, diagnosis, medical treatment and interventions for vascular disease. A member of the Committee on Publication Ethics (COPE)